-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, R9+LUc46+ohu8pbE8uMIucabLXlOkdwO8+7U9+7OvN445qnc7JeegY5L9kCKk3pY Vckm89WaS9jQjJyXjNCoSA== 0000950005-00-000249.txt : 20000215 0000950005-00-000249.hdr.sgml : 20000215 ACCESSION NUMBER: 0000950005-00-000249 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LYNX THERAPEUTICS INC CENTRAL INDEX KEY: 0000913275 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 943161073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-45671 FILM NUMBER: 537651 BUSINESS ADDRESS: STREET 1: 3832 BAY CENTER PL CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 5106709300 MAIL ADDRESS: STREET 1: 3832 BAY CENTER PLACE CITY: HAYWARD STATE: CA ZIP: 94545 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: U S VENTURE PARTNERS IV L P CENTRAL INDEX KEY: 0001030241 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 2180 SAND HILL ROAD SUITE 300 CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 4158549080 MAIL ADDRESS: STREET 1: 2180 SAND HILL ROAD STREET 2: SUITE 300 CITY: MENLO PARK STATE: CA ZIP: 94025 SC 13D/A 1 AMENDMENT 1 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Lynx Therapeutics, Inc. ------------------------------ (Name of Issuer) Common Stock ------------------------------ (Title of Class of Securities) 551812100 -------------- (CUSIP Number) Michael P. Maher c/o U.S. Venture Partners 2180 Sand Hill Road, Suite 300 Menlo Park, CA 94025 (650) 854-9080 -------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) January 11, 2000 ------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ]. SCHEDULE 13D - --------------------- CUSIP NO. 551812100 - --------------------- 1 NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON U.S. Venture Partners IV, L.P. 94-3193188 -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] -------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable -------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] -------------------------------------------------------------------------- 6 CITZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 NUMBER OF --------------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY --------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING 0 PERSON --------------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 0 --------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 -------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] NOT APPLICABLE ------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0% -------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN -------------------------------------------------------------------------- 2 SCHEDULE 13D - --------------------- CUSIP NO. 551812100 - --------------------- 1 NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Second Ventures II, L.P. ("SV II") 94-3200353 -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] -------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable -------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] -------------------------------------------------------------------------- 6 CITZENSHIP OR PLACE OF ORGANIZATION Cayman Islands -------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 NUMBER OF --------------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY --------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING 0 PERSON --------------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 0 --------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 -------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ] NOT APPLICABLE ------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0% -------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN -------------------------------------------------------------------------- 3 SCHEDULE 13D - --------------------- CUSIP NO. 551812100 - --------------------- 1 NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON USVP Entrepreneur Partners II, L.P. ("UEP II) 94-3203198 -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] -------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable -------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] -------------------------------------------------------------------------- 6 CITZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 NUMBER OF --------------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY --------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING 0 PERSON --------------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 0 --------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 -------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] NOT APPLICABLE ------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0% -------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN -------------------------------------------------------------------------- 4 SCHEDULE 13D - --------------------- CUSIP NO. 551812100 - --------------------- 1 NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Presidio Management Group IV, L.P. ("PMG IV") 94-3193187 -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] -------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable -------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] -------------------------------------------------------------------------- 6 CITZENSHIP OR PLACE OF ORGANIZATION Delaware -------------------------------------------------------------------------- 7 SOLE VOTING POWER 0 NUMBER OF --------------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY --------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING 0 PERSON --------------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 0 --------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 0 -------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] NOT APPLICABLE ------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0% -------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* PN -------------------------------------------------------------------------- 5 SCHEDULE 13D - --------------------- CUSIP NO. 551812100 - --------------------- 1 NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON William K. Bowes, Jr. ("Bowes") -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] -------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------- 4 SOURCE OF FUNDS* Not Applicable -------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] -------------------------------------------------------------------------- 6 CITZENSHIP OR PLACE OF ORGANIZATION United States -------------------------------------------------------------------------- 7 SOLE VOTING POWER 53,007 shares. NUMBER OF --------------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY --------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING 53,007 shares. PERSON --------------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 0 --------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 53,007 shares. -------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] NOT APPLICABLE ------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.5% -------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN -------------------------------------------------------------------------- 6 SCHEDULE 13D - --------------------- CUSIP NO. 551812100 - --------------------- 1 NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Irwin Federman ("Federman") -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] -------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable -------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] -------------------------------------------------------------------------- 6 CITZENSHIP OR PLACE OF ORGANIZATION United States -------------------------------------------------------------------------- 7 SOLE VOTING POWER 28,448 shares. NUMBER OF --------------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY --------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING 28,448 shares. PERSON --------------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 0 --------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 28,448 shares. -------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] NOT APPLICABLE ------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.2% -------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN -------------------------------------------------------------------------- 7 SCHEDULE 13D - --------------------- CUSIP NO. 551812100 - --------------------- 1 NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Steven M. Krausz ("Krausz") -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ] (b) [X] -------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable -------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] -------------------------------------------------------------------------- 6 CITZENSHIP OR PLACE OF ORGANIZATION United States -------------------------------------------------------------------------- 7 SOLE VOTING POWER 11,774 shares. NUMBER OF --------------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY --------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING 11,774 shares. PERSON --------------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 0 --------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 11,774 shares. -------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] NOT APPLICABLE ------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.1% -------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN -------------------------------------------------------------------------- 8 SCHEDULE 13D - --------------------- CUSIP NO. 551812100 - --------------------- 1 NAMES OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Philip M. Young ("Young") -------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ] (b) [X] -------------------------------------------------------------------------- 3 SEC USE ONLY -------------------------------------------------------------------------- 4 SOURCE OF FUNDS Not Applicable -------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [ ] -------------------------------------------------------------------------- 6 CITZENSHIP OR PLACE OF ORGANIZATION United States -------------------------------------------------------------------------- 7 SOLE VOTING POWER 28,448 shares. NUMBER OF --------------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY 0 OWNED BY --------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING 28,448 shares. PERSON --------------------------------------------------------- WITH 10 SHARED DISPOSITIVE POWER 0 --------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 28,448 shares. -------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ] NOT APPLICABLE ------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 0.2% -------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON* IN -------------------------------------------------------------------------- 9 Security and Issuer. Item 1. Security and Issuer. This Schedule 13D relates to the common stock, no par value (the "Common Stock"), of Lynx Therapeutics, Inc.(the "Issuer"). The principal executive office and mailing address of the Issuer is 3832 Bay Center Place, Hayward, CA 94545. Item 2. Identity and Background. (a) (b) and (c) This Schedule 13D is filed on behalf U.S. Venture Partners IV, L.P., Second Ventures II, L.P., USVP Entrepreneur Partners II, L.P., Presidio Management Group IV, L.P., William K. Bowes, Jr., Irwin Federman, Steven M. Krausz and Philip M. Young. The foregoing entities and individuals are collectively referred to as the "Reporting Persons". The Reporting Person's citizenship and principal occupation are as follows: Principal Occupation Name Business Address Citizenship or Employment - ---- ---------------- ----------- ------------- U.S. Venture 2180 Sand Hill Road Delaware Not applicable Partners IV, L.P. Suite 300 Menlo Park, CA 94025 Second Ventures 2180 Sand Hill Road Cayman Not applicable II, L.P. Suite 300 Islands Menlo Park, CA 94025 USVP Entrepreneur 2180 Sand Hill Road Delaware Not applicable Partners II, L.P. Suite 300 Menlo Park, CA 94025 Presidio Management 2180 Sand Hill Road Delaware Not applicable Group IV, L.P. Suite 300 Menlo Park, CA 94025 William K. Bowes, Jr. 2180 Sand Hill Road United States General Partner Suite 300 Menlo Park, CA 94025 Irwin Federman 2180 Sand Hill Road United States General Partner Suite 300 Menlo Park, CA 94025 10 Steven M. Krausz 2180 Sand Hill Road United States General Partner Suite 300 Menlo Park, CA 94025 Philip M. Young 2180 Sand Hill Road United States General Partner Suite 300 Menlo Park, CA 94025 (d) To the best knowledge of the Reporting Person, during the past five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). (e) To the best knowledge of the Reporting Person, during the past five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and therefore was not and is not subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws. Item 3. Source and Amount of Funds or Other Consideration. On January 11, 2000 the Reporting Persons disposed of certain shares of Common Stock of the Issuer. Item 4. Purpose of Transaction. The Reporting Persons disposed of the securities to decrease their respective equity interests in the Issuer. Depending upon market conditions and other factors, the Reporting Persons may acquire additional securities of the Issuer, in the open market, in privately negotiated transactions or otherwise. Alternatively, depending upon market conditions and other factors, the Reporting Persons may, from time to time, dispose of some or all of the securities of the Issuer. Although the Reporting Persons reserve the right to develop plans or proposals in the future with respect to the following items, except as set forth above at the present time he has no plans or proposals that relate to or would result in any of the following: (a) the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; 11 (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer's business or corporate structure; (g) changes in the Issuer's charter, bylaws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Securities Exchange Act of 1934; or (j) any action similar to any of those enumerated in (a) through (i) above. Item 5. Interest in Securities of the Issuer. (a), (b) According to information furnished to the Reporting Persons by the Issuer, there were 11,108,000 shares of Common Stock issued and outstanding as of September 30, 1999. Based on such information, after taking into account the transactions described in Item 5(c) below, the Reporting Persons report the following direct holdings and corresponding percentage interests in the Common Stock (computed in accordance with Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended): Shares Shares of Common Underlying Percentage Name Stock Owned Options Total Owned U.S. Venture Partners IV, L.P. 0 0 0 0.0% Second Ventures II, L.P. 0 0 0 0.0% 12 USVP Entrepreneur Partners II, L.P. 0 0 0 0.0% Presidio Management Group IV, L.P. 0 0 0 0.0% William K. Bowes, Jr 53,007* 0 53,007 0.5% Irwin Federman 28,448 0 28,448 0.2% Steven M. Krausz 11,774 0 11,774 0.1% Philip M. Young 28,448 0 28,448 0.2% - ---------- * - Includes 17,606 shares held by the William K. Bowes Jr. Charitable Trust dtd 10/16/91 for which Mr. Bowes is the trustee. (c) The Reporting Person did not effect any transactions other than those set forth in Items 3 and 4 above. (d) Not applicable. (e) The Reporting Persons ceased to be the beneficial owner of more than five percent of the Common Stock of the Issuer on January 11, 2000. Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. Not applicable. Item 7. Material to Be Filed as Exhibits. See Exhibit A - Agreement to Joint Filing on Schedule 13D. See Exhibit B - Reference to Michael Maher as Attorney-in-Fact. 13 Page 19 of 20 Pages SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 24, 2000 U.S. Venture Partners IV, L.P. ---------------------------------------- By Presidio Management Group IV, L.P. Signature Its General Partner Michael P. Maher Chief Financial Officer/Attorney-In-Fact Second Ventures II, L.P. ---------------------------------------- By Presidio Management Group IV, L.P. Signature Its General Partner Michael P. Maher Chief Financial Officer/Attorney-In-Fact U.S.V. Entrepreneur Partners II, L.P. ---------------------------------------- By Presidio Management Group IV, L.P. Signature Its General Partner Michael P. Maher Chief Financial Officer/Attorney-In-Fact Presidio Management Group IV, L.P. ---------------------------------------- A Delaware Limited Partnership Signature Michael P. Maher Chief Financial Officer/Attorney-In-Fact William K. Bowes, Jr. ---------------------------------------- Michael P. Maher Attorney-In-Fact Irwin Federman ---------------------------------------- Michael P. Maher Attorney-In-Fact 14 Steven M. Krausz ---------------------------------------- Michael P. Maher Attorney-In-Fact Philip M. Young ---------------------------------------- Michael P. Maher Attorney-In-Fact 15 EXHIBIT INDEX Found on Sequentially Exhibit Numbered Page - ------- ------------- Exhibit A: Agreement of Joint Filing 18 Exhibit B: Reference to Michael P. Maher as Attorney-In-Fact 20 EXHIBIT A Agreement of Joint Filing The undersigned hereby agree that a single Schedule 13D (or any amendment thereto) relating to the Common Stock of Lynx Therapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D. Dated: January 24, 2000 U.S. Venture Partners IV, L.P. ---------------------------------------- By Presidio Management Group IV, L.P. Signature Its General Partner Michael P. Maher Chief Financial Officer/Attorney-In-Fact Second Ventures II, L.P. ---------------------------------------- By Presidio Management Group IV, L.P. Signature Its General Partner Michael P. Maher Chief Financial Officer/Attorney-In-Fact U.S.V. Entrepreneur Partners II, L.P. ---------------------------------------- By Presidio Management Group IV, L.P. Signature Its General Partner Michael P. Maher Chief Financial Officer/Attorney-In-Fact Presidio Management Group IV, L.P. ---------------------------------------- A Delaware Limited Partnership Signature Michael P. Maher Chief Financial Officer/Attorney-In-Fact William K. Bowes, Jr. ---------------------------------------- Michael P. Maher Attorney-In-Fact 17 Irwin Federman ---------------------------------------- Michael P. Maher Attorney-In-Fact Steven M. Krausz ---------------------------------------- Michael P. Maher Attorney-In-Fact Philip M. Young ---------------------------------------- Michael P. Maher Attorney-In-Fact 18 EXHIBIT B REFERENCE TO MICHAEL MAHER AS ATTORNEY-IN-FACT Michael P. Maher has signed the enclosed documents as Attorney-In-Fact. Note that copies of the applicable Power of Attorneys are already on file with the appropriate agencies. 19 -----END PRIVACY-ENHANCED MESSAGE-----